错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Jerusalem’s CoVID-19 Experience—The Effect of Ethnicity on Disease Prevalence and Adherence to Testing

  • Michael Sorotzky,
  • Allon Raphael,
  • Adin Breuer,
  • Ma’aran Odeh,
  • Roni Gillis,
  • Michal Gillis,
  • Roaia Shibli,
  • Judith Fiszlinski,
  • Nurit Algur,
  • Sophie Magen,
  • Orli Megged,
  • Yechiel Schlesinger,
  • Joseph Mendelovich,
  • Giora Weiser,
  • Elihay Berliner,
  • Yuval Barak-Corren,
  • Eyal Heiman

摘要

Background

The management of the SARS-CoV-2 pandemic depends amongst other factors on disease prevalence in the general population. The gap between the true rate of infection and the detected rate of infection may vary, especially between sub-groups of the population. Identifying subpopulations with high rates of undetected infection can guide authorities to direct resource distribution in order to improve health equity.

Methods

A cross-sectional epidemiological survey was conducted between April and July 2021 in the Pediatric Emergency Department of the Shaare Zedek Medical Center, Jerusalem, Israel. We compared three categories: unconfirmed disease (UD), positive serology test result with no history of positive PCR; confirmed disease (CD), history of a positive PCR test result, regardless of serology test result; and no disease (ND), negative serology and no history of PCR. These categories were applied to local prevailing subpopulations: ultra-orthodox Jews (UO), National Religious Jews (NRJ), secular Jews (SJ), and Muslim Arabs (MA).

Results

Comparing the different subpopulations groups, MAs and UOs had the greatest rate of confirmed or unconfirmed disease. MA had the highest rate of UD and UO had the highest rate of CD. UD significantly correlated with ethnicity, with a low prevalence in NRJ and SJ. UD was also associated with larger family size and housing density defined as family size per number of rooms.

Conclusion

This study highlights the effect of ethnicity on disease burden. These findings should serve to heighten awareness to disease burden in weaker populations and direct a suitable prevention program to each subpopulation’s needs. Early awareness and possible intervention may lower morbidity and mortality.